Related Experiment Videos

Does elevated cardiac troponin I in patients with unstable angina predict ischemia on stress testing?

W F Fearon1, F H Lee, V F Froelicher

  • 1Stanford University Medical Center, California 94305-5406, USA. wfearon@stanford.edu

The American Journal of Cardiology
|December 22, 1999
PubMed

Insights

Elevated cardiac troponin I levels in patients with unstable angina indicate potential ischemia on stress testing. This biomarker also predicts future cardiac events, aiding clinical decision-making.

Area of Science:

  • Cardiology
  • Clinical Biochemistry

Background:

  • Acute coronary syndromes (ACS) require accurate diagnostic tools.
  • Unstable angina is a critical presentation of ACS.
  • Cardiac biomarkers are essential for risk stratification in ACS.

Purpose of the Study:

  • To determine if elevated cardiac troponin I (cTnI) predicts myocardial ischemia in patients with unstable angina.
  • To assess the association of cTnI with future cardiac events in this patient group.

Main Methods:

  • Retrospective analysis of patients presenting with chest pain and normal creatine kinase (CK) levels.
  • Measurement of cardiac troponin I levels.
  • Performance of stress testing to detect ischemia.

Main Results:

  • Elevated cTnI levels were significantly associated with the presence of ischemia on stress testing.
  • Patients with elevated cTnI also showed a higher incidence of future cardiac events.
  • The predictive value of cTnI was observed even with normal CK levels.

Conclusions:

  • Elevated cardiac troponin I is a valuable predictor of ischemia in unstable angina patients.
  • cTnI measurement aids in identifying patients at higher risk for adverse cardiac outcomes.
  • This biomarker assists physicians in guiding patient evaluation and management for ACS.

Related Concept Videos